Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)

NCT01678131 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Vaniprevir 600 mg
BIOLOGICAL: Peg-IFN alfa-2b
BIOLOGICAL: Ribavirin
PROCEDURE: Liver samples from FNA
DRUG: Vaniprevir 300 mg
PROCEDURE: Liver samples from CNB

Sponsor

Merck Sharp & Dohme LLC